Boardroom Alpha
Meeting calendar
PSNL · Annual meeting · Tuesday, May 12, 2026

Personalis Inc

2 nominees · 3 ballot items.

Election of two Class I directors; ratification of BDO USA, P.C. as the Company’s independent registered public accounting firm for 2026; and a non-binding, advisory vote to approve the compensation of the Company’s named executive officers (say-on-pay).

Market cap
$1.6B
1Y TSR
+99.0%
Board grade
B-
Record date
Mar 17, 2026
Filing
DEF 14A
Meeting concluded · May 12, 2026

Follow how the vote landed and what changed on Personalis Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect two nominees (Olivia K. Bloom and Woodrow A. Myers, Jr., M.D.) as Class I directors to hold office until the 2029 Annual Meeting and until their successors are elected and qualified.

  2. 2

    Ratification of Selection of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of BDO USA, P.C. as Personalis’ independent registered public accounting firm for the fiscal year ending December 31, 2026.

  3. 3

    Advisory Approval of Named Executive Officer Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement pursuant to Item 402 of Regulation S-K.

    More detail

    This management proposal requests a non-binding, advisory approval of the Company’s executive compensation program as disclosed in the proxy materials (a "say-on-pay" vote required by the Dodd-Frank Act and SEC rules). Management is seeking shareholder approval not to change compensation directly but to solicit stockholder feedback on the overall design and philosophy—specifically a pay-for-performance approach that ties a substantial portion of named executive officers’ compensation to performance-based cash bonuses and equity awards. The Company discloses that a significant portion of CEO and other NEO pay is at-risk and linked to measurable corporate objectives and long-term equity value creation, and that annual equity grants include both service-based options and performance-based restricted stock units tied to operational and reimbursement milestones. The Board has adopted a policy to solicit this advisory vote annually, reflecting prior stockholder preference (the 2025 say-on-pay received ~96.12% support) and to facilitate ongoing stockholder engagement on pay alignment. While the vote is non-binding, the Board and Compensation Committee state they will consider the outcome when making future compensation decisions, using it as an input to calibrate pay levels, incentives, and performance metrics. The proposal sits in the broader governance context of aligning management incentives with commercialization, reimbursement, and clinical validation milestones that are material to the Company’s strategic plan and shareholder value. The Board’s recommendation to vote “For” is justified by the Committee’s view that the program attracts and retains management, emphasizes long-term equity alignment, and uses rigorous, pre-established performance targets; opposition would typically reflect concerns about pay quantum, metric selection, or perceived misalignment between pay and recent financial performance.

Director elections

Nominees on the ballot2

Ownership

Top institutional holders10

Latest 13F quarter
1Merck Co., Inc.13.4%14,044,943$89M
2Lightspeed Management Company, L.L.C.7.8%8,160,734$52M
3ARK Investment Management LLC7.6%7,944,112$51M
4T. Rowe Price Investment Management, Inc.4.5%4,758,091$30M
5AMERIPRISE FINANCIAL INC4.4%4,622,921$29M
6Aberdeen Group plc3.3%3,488,308$22M
7Deep Track Capital, LP2.9%3,000,000$19M
8VANGUARD CAPITAL MANAGEMENT LLC2.7%2,868,463$18M
9AMERIPRISE FINANCIAL INC2.7%2,834,074$18M
10BlackRock, Inc.2.4%2,528,779$16M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Personalis Inc 2026 annual meeting?
Personalis Inc (PSNL) holds its 2026 annual shareholder meeting on Tuesday, May 12, 2026.
What is the record date for the Personalis Inc 2026 meeting?
The record date for the Personalis Inc 2026 meeting is Tuesday, March 17, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Personalis Inc's 2026 meeting?
The board is presenting 2 director nominees at the Personalis Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Personalis Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Personalis Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer